Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats

Many neuroprotective agents have been effective in experimental stroke, yet few have translated into clinical application. One reason for this may be failure to consider clinical comorbidities/risk factors in experimental models. We have shown that a naturally occurring interleukin-1 receptor antago...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pradillo, Jesus M, Denes, Adam, Greenhalgh, Andrew D, Boutin, Herve, Drake, Caroline, McColl, Barry W, Barton, Eleanor, Proctor, Spencer D, Russell, James C, Rothwell, Nancy J, Allan, Stuart M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2012
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434631/
https://ncbi.nlm.nih.gov/pubmed/22781338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2012.101
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados